Retinoblastoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
{{Retinoblastoma}} | {{Retinoblastoma}} | ||
==Overview== | ==Overview== | ||
Retinoblastoma was first described in 1809 by Dr. James Wardrop. Then, Dr. Flexner, in 1891, was the first to discover the rosette structure within the [[tumor]]. In 1953, Dr. Kupfer was the first [[ophthalmologist]] who tried a combination of [[chemotherapy]] and [[radiotherapy]] for the treatment of the [[tumor]]. | |||
==Historical Perspective == | ==Historical Perspective == | ||
*In 1657, Dr. Petrus Pawius, an [[anatomist]] from Amsterdam, described a [[tumor]] resembling | *In 1657, Dr. Petrus Pawius, an [[anatomist]] from Amsterdam, described a [[tumor]] resembling retinoblastoma for the first time.<ref name="Albert1987">{{cite journal|last1=Albert|first1=Daniel M.|title=Historic Review of Retinoblastoma|journal=Ophthalmology|volume=94|issue=6|year=1987|pages=654–662|issn=01616420|doi=10.1016/S0161-6420(87)33407-4}}</ref> | ||
*In 1767, Dr. Hayes, a [[surgeon]], was first to describe the [[bilateral]] form of | *In 1767, Dr. Hayes, a [[surgeon]], was first to describe the [[bilateral]] form of retinoblastoma. | ||
*In 1809, Dr. James Wardrop, Scottish [[surgeon]] | *In 1809, Dr. James Wardrop, a Scottish [[surgeon]] and [[ophthalmologist]], first described the retinoblastoma [[tumor]]. | ||
*In 1971, Dr. Knudson proposed the two-hit hypothesis which gives the light to the [[pathogenesis]] of the [[familial]] and sporadic form of the [[tumor]].<ref name="pmid5279523">{{cite journal |vauthors=Knudson AG |title=Mutation and cancer: statistical study of retinoblastoma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=68 |issue=4 |pages=820–3 |date=April 1971 |pmid=5279523 |pmc=389051 |doi= |url=}}</ref> | *In 1971, Dr. Knudson proposed the two-hit [[hypothesis]] which gives the light to the [[pathogenesis]] of the [[familial]] and sporadic form of the [[tumor]].<ref name="pmid5279523">{{cite journal |vauthors=Knudson AG |title=Mutation and cancer: statistical study of retinoblastoma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=68 |issue=4 |pages=820–3 |date=April 1971 |pmid=5279523 |pmc=389051 |doi= |url=}}</ref> | ||
*In 1891, Dr. Flexner was the first to discover the rosette structure within the [[tumor]].<ref name="Albert1987">{{cite journal|last1=Albert|first1=Daniel M.|title=Historic Review of Retinoblastoma|journal=Ophthalmology|volume=94|issue=6|year=1987|pages=654–662|issn=01616420|doi=10.1016/S0161-6420(87)33407-4}}</ref> | *In 1891, Dr. Flexner was the first to discover the rosette structure within the [[tumor]].<ref name="Albert1987">{{cite journal|last1=Albert|first1=Daniel M.|title=Historic Review of Retinoblastoma|journal=Ophthalmology|volume=94|issue=6|year=1987|pages=654–662|issn=01616420|doi=10.1016/S0161-6420(87)33407-4}}</ref> | ||
*In 1920s Verhoeff claimed that the [[tumor]] arose from [[embryonic]] [[retinal]] [[cells]] and hence proposed the name " | *In the 1920s, Verhoeff claimed that the [[tumor]] arose from [[embryonic]] [[retinal]] [[cells]] and hence proposed the name "retinoblastoma". | ||
* | *Retinoblastoma is the first [[cancer]] in which the role of [[genetics]] was discovered.<ref name="pmid25971166">{{cite journal |vauthors=Dimaras H |title=Retinoblastoma genetics in India: From research to implementation |journal=Indian J Ophthalmol |volume=63 |issue=3 |pages=219–26 |date=March 2015 |pmid=25971166 |pmc=4448234 |doi=10.4103/0301-4738.156917 |url=}}</ref> | ||
*In 1977, Dr. Jakobiec and colleagues were the first to describe the association between [[bilateral]] | *In 1977, Dr. Jakobiec and colleagues were the first to describe the association between [[bilateral]] [[Ocular|intraocular]] retinoblastoma and [[Cranium|intracranial]] [[malignancy]], also known as trilateral retinoblastoma.<ref name="pmid870165">{{cite journal |vauthors=Jakobiec FA, Tso MO, Zimmerman LE, Danis P |title=Retinoblastoma and intracranial malignancy |journal=Cancer |volume=39 |issue=5 |pages=2048–58 |date=May 1977 |pmid=870165 |doi= |url=}}</ref> | ||
===Landmark Events in the Development of Treatment Strategies=== | ===Landmark Events in the Development of Treatment Strategies=== | ||
*In 1851, Mr. Helmholtz invented [[ophthalmoscope]], with which the study of [[tumor]] became | *In 1851, Mr. Helmholtz invented [[ophthalmoscope]], with which the study of [[tumor]] became possible.<ref name="Albert1987">{{cite journal|last1=Albert|first1=Daniel M.|title=Historic Review of Retinoblastoma|journal=Ophthalmology|volume=94|issue=6|year=1987|pages=654–662|issn=01616420|doi=10.1016/S0161-6420(87)33407-4}}</ref> | ||
*Dr. James Wardrop was also the first who proposed the idea that early [[enucleation]] of the [[eye]] might save the life of the patient. | *Dr. James Wardrop was also the first who proposed the idea that early [[enucleation]] of the [[eye]] might save the life of the [[patient]]. | ||
*Dr. William Mackenzie of Glasgow was the first who suggested a less painful method for the [[enucleation]] of the [[eye]]. | *Dr. William Mackenzie of Glasgow was the first who suggested a less painful method for the [[enucleation]] of the [[eye]]. | ||
*In 1903, Dr. Hilgartner, was the first who tried to treat the [[tumor]] via [[x-ray]]. | *In 1903, Dr. Hilgartner, was the first who tried to treat the [[tumor]] via [[x-ray]]. | ||
*In 1953, Dr. Kupfer was the first [[ophthalmologist]] who tried a combination of [[chemotherapy]] (a nitrogen mustard agent | *In 1953, Dr. Kupfer was the first [[ophthalmologist]] who tried a combination of [[chemotherapy]] (a [[nitrogen mustard]] agent) and [[radiotherapy]] for the treatment of the [[tumor]]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:33, 3 June 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Simrat Sarai, M.D. [3]
|
Retinoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Retinoblastoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Retinoblastoma historical perspective |
|
Risk calculators and risk factors for Retinoblastoma historical perspective |
Overview
Retinoblastoma was first described in 1809 by Dr. James Wardrop. Then, Dr. Flexner, in 1891, was the first to discover the rosette structure within the tumor. In 1953, Dr. Kupfer was the first ophthalmologist who tried a combination of chemotherapy and radiotherapy for the treatment of the tumor.
Historical Perspective
- In 1657, Dr. Petrus Pawius, an anatomist from Amsterdam, described a tumor resembling retinoblastoma for the first time.[1]
- In 1767, Dr. Hayes, a surgeon, was first to describe the bilateral form of retinoblastoma.
- In 1809, Dr. James Wardrop, a Scottish surgeon and ophthalmologist, first described the retinoblastoma tumor.
- In 1971, Dr. Knudson proposed the two-hit hypothesis which gives the light to the pathogenesis of the familial and sporadic form of the tumor.[2]
- In 1891, Dr. Flexner was the first to discover the rosette structure within the tumor.[1]
- In the 1920s, Verhoeff claimed that the tumor arose from embryonic retinal cells and hence proposed the name "retinoblastoma".
- Retinoblastoma is the first cancer in which the role of genetics was discovered.[3]
- In 1977, Dr. Jakobiec and colleagues were the first to describe the association between bilateral intraocular retinoblastoma and intracranial malignancy, also known as trilateral retinoblastoma.[4]
Landmark Events in the Development of Treatment Strategies
- In 1851, Mr. Helmholtz invented ophthalmoscope, with which the study of tumor became possible.[1]
- Dr. James Wardrop was also the first who proposed the idea that early enucleation of the eye might save the life of the patient.
- Dr. William Mackenzie of Glasgow was the first who suggested a less painful method for the enucleation of the eye.
- In 1903, Dr. Hilgartner, was the first who tried to treat the tumor via x-ray.
- In 1953, Dr. Kupfer was the first ophthalmologist who tried a combination of chemotherapy (a nitrogen mustard agent) and radiotherapy for the treatment of the tumor.
References
- ↑ 1.0 1.1 1.2 Albert, Daniel M. (1987). "Historic Review of Retinoblastoma". Ophthalmology. 94 (6): 654–662. doi:10.1016/S0161-6420(87)33407-4. ISSN 0161-6420.
- ↑ Knudson AG (April 1971). "Mutation and cancer: statistical study of retinoblastoma". Proc. Natl. Acad. Sci. U.S.A. 68 (4): 820–3. PMC 389051. PMID 5279523.
- ↑ Dimaras H (March 2015). "Retinoblastoma genetics in India: From research to implementation". Indian J Ophthalmol. 63 (3): 219–26. doi:10.4103/0301-4738.156917. PMC 4448234. PMID 25971166.
- ↑ Jakobiec FA, Tso MO, Zimmerman LE, Danis P (May 1977). "Retinoblastoma and intracranial malignancy". Cancer. 39 (5): 2048–58. PMID 870165.